Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study
Nichola Johnson(Institute of Cancer Research), Alfons Meindl(Helmholtz Zentrum München), Marjanka K. Schmidt(University of Cambridge), Frederik Marmé(Heidelberg University), Peter A. Fasching(Universitätsklinikum Erlangen), Stefan P. Renner(Universitätsklinikum Erlangen), Michael E. Jones(Institute of Cancer Research), Frank Dudbridge(University of Cambridge), Michael J. Kerin(Ollscoil na Gaillimhe – University of Galway), Thérèse Truong(Université Paris-Sud), Annegien Broeks, Kenneth Muir(Manchester Academic Health Science Centre), F. Ménégaux(Université Paris-Sud), Pascal Guénel(Inserm), Ian Tomlinson(University of Oxford), Roger L. Milne(The University of Melbourne), Emilie Cordina(Inserm), Arif B. Ekici(University Medical Center Groningen), Leslie Bernstein(National Cancer Institute), Javier Benı́tez(Spanish National Cancer Research Centre), Elizabeth Folkerd(Royal Marsden Hospital), José Ignacio Arias Pérez, Elinor J. Sawyer(King's College London), Heiko Müller(Munich Leukemia Laboratory (Germany)), Christina Clarke Dur(Cancer Prevention Institute of California), Argyrios Ziogas(University of Copenhagen), Nick Orr(United States Department of Health and Human Services), Stig E. Bojesen(University of Copenhagen), Artitaya Lophatananon(Manchester Academic Health Science Centre), M. Pilar Zamora(Universidad Autónoma de Madrid), Hermann Brenner(Universidad de Granada), Femke Atsma(Radboud University Nijmegen), Hoda Anton‐Culver(University of California, Irvine), Børge G. Nordestgaard(Gentofte Hospital), Christof Sohn, Aida Karina Dieffenbach(German Cancer Research Center), Andreas Schneeweiß(German Cancer Research Center), Melissa C. Southey(The University of Melbourne), Gillian S. Dite(University of Melbourne), Barbara Burwinkel(German Cancer Research Center), Matthias W. Beckmann, John L. Hopper(The University of Melbourne), Minouk J. Schoemaker(Institute of Cancer Research), Laura J. van’t Veer(University of California, San Francisco), Lorna J. Gibson(London School of Hygiene & Tropical Medicine), Carmel Apicella(The University of Melbourne), Henrik Flyger(Herlev Hospital), Nicola Miller(Ollscoil na Gaillimhe – University of Galway), Ben P. Haynes(Institute of Cancer Research), Volker Arndt(German Cancer Research Center)
Cited by 46
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k